Don't assume meds within a class are all created equal.
Click here for previous newsletters.
1. Counselling Conundrum: a real question from a patient
2. Concise Conclusion: a straight-forward patient-friendly answer
3. Quick Wrap-up
Clearly, there are nuances that may not be captured in this format. The goal here is to provide you with helpful counselling tips which often draw from multiple sources or those which are not commonly accessed by busy healthcare providers serving the community.
Counselling Conundrum: "I've been taking rivaroxaban for a while now for my heart, but I've seen commercials for other blood thinners. I am 35 years old; is mine the best one for me?"
Concise Conclusion: Great question! There are really four other members of rivaroxaban's family; apixaban, edoxaban, and dabigatran. While they all seem to work the same to prevent strokes, apixaban seems to cause less bleeding. However, apixaban is dosed twice daily, so that may not be ideal for you. If things are going well for you, I wouldn't switch.
Quick Wrap-up: Apixaban seems to cause less significant bleeding, and rivaroxaban and dabigatran are on the Beers list. We try to keep in mind that BID dosing is a deal-breaker for many patients, and sometimes it's best not to "rock the boat" if patients aren't experiencing side effects.
Dive Deeper
We hope you have found this useful. A reply to this email with any feedback or topic suggestion you may have would be greatly appreciated. Your input will be the key to making this newsletter the best it can be.
Comments